Clinical Trial Update: Study of an Investigational Drug, ASP3026, in Patients With Advanced Malignancies (Solid Tumors and B-Cell Lymphoma) [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial of ASP3026 in patients with advanced malignancies, including solid tumors and B-cell lymphoma, has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• B-cell Lymphoma
• Solid Tumors

Drugs mentioned

• ASP3026

Snippet

Sponsor: Astellas Pharma Inc | Conditions: Advanced Malignancies, Positive for Anaplastic Lymphoma Kinase | Phase 1 | Status: COMPLETED